By Marie Rosenthal, MS
A single HIV viral load test processed by a laboratory may not reliably detect HIV among some people taking long-acting, injectable cabotegravir (CAB-LA; Apretude, ViiV Healthcare) for HIV pre-exposure prophylaxis (PrEP) because of an increased likelihood of false-positive results, according to a study presented at AIDS 2024 in Munich, Germany (abstract OAE0406LB).